人胚胎来源细胞在生物医药领域的 应用历史及研究和监管进展.

Since the establishment of the first human diploid cell line derived from aborted fetal tissue in the 1960s, human embryoderived cells have been widely used in biomedical field and significantly contributes to improving human health. In recent years, human pluripotent stem cells, including human embryonic stem cells (hESCs), have shown great therapeutic potential in regenerative medicine, and thus received great attention from governments and the public. However, due to various factors such as history, culture, religious beliefs, ethics and morality, research and application involving human embryo-derived cells have been controversial worldwide. This study explores the history and progress of human embryo-derived cells in the field of biomedicine, and analyzes the evolution of regulatory systems in different countries, with the aim of facilitating the improvement of China's regulatory framework and technical requirements in this field. [ABSTRACT FROM AUTHOR]